 |
 |

Combined Therapy for Cancer of the Laryngopharynx
Joseph L. Goldman, MD;
Melvin J. Gunsberg, MD;
William H. Friedman, MD;
John R. Ryan, MD;
Bruce S. Bloom, MD
Arch Otolaryngol. 1970;92(3):221-225.
Abstract
Fifty-three patients with laryngeal cancer have been treated with combined therapy at the Mount Sinai Hospital since 1958. Thirty-five are alive and well. Six are dead of disease and only three of these patients developed local recurrences. Three had distant metastases. A histopathological study consisting of en bloc serial sectioning of laryngeal and neck specimens has demonstrated several advantages to the use of combined therapy. Among these are the recognition and total surgical extirpation of isolated postradiation nests of laryngeal cancer cells throughout the original tumor site. In addition, incubation of laryngeal cancer in vitro with tritiated thymidine has demonstrated cell viability after 5,500 rads of preoperative radiation.
Author Affiliations
New York
From the Department of Otolaryngology, Mount Sinai Medical Center, New York.
Footnotes
Accepted for publication March 23, 1970.
Reprint requests to Department of Otolaryngology, Mount Sinai Medical Center, Fifth Ave and 100th St, New york 10029 (Dr. Goldman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Advanced Laryngeal Cancer: Relevance of Pathologic Stage to Survival and Therapy
Decker et al.
Arch Otolaryngol Head Neck Surg 1986;112:1163-1167.
ABSTRACT
Control of Localized Cancer: Combination of Preoperative Irradiation and Surgery
Stevens and Moss
JAMA 1975;232:1158-1160.
ABSTRACT
|